<DOC>
	<DOC>NCT02957643</DOC>
	<brief_summary>The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.</brief_summary>
	<brief_title>Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement</brief_title>
	<detailed_description />
	<mesh_term>Iron</mesh_term>
	<criteria>1. Age more or equal of 18 years 2. Registration consent 3. Have complete 12h week of pregnancy 4. Hemoglobin levels &lt;10,5 ptl 5. Hematocrit &lt; 32 % 1. Age &lt;18 years 2. Absent registration consent 3. Step of pregnancy less than 12 weeks 4. Coadministration formulations iron oral or parenterally 5. Background of liver kirrosis 6. Background of aimosidirosis 7. Background acquired or chronic aimatochromatosis 8. Aplastic , Hemolytic anemia and chronic diseases 9. Chronic pancreatitis 10. Subjective renal or/and liver disease 11. Hypothyroidism or yperthyreoeidismos</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>